Thesis project: PEPtides And Products Inhibiting bacterial Growth

Laboratories: SyMMES & IBS - 01/11/2023 - 31/10/2026

Thesis project holders: Yoann ROUPIOZ and Sandrine BOISSET
Young thesis researcher: Lucie BASTIEN

Abstract: The global burden of bacterial infections and antimicrobial resistance highlight the need for rapid diagnostic approaches and new therapies. Antimicrobial peptides (AMPs) are defence biomolecules produced by organisms to protect against pathogens. Integrated into a microarray-based surface plasmon resonance imaging biosensor, they enabled single-step bacterial identification within 15 h under blood infection-relevant conditions. Among the AMPs used on the microarray de novo-designed peptides displayed remarkable antimicrobial activity. Sequence optimisation improved their solubility and reduced their toxicity towards eukaryotic cells while preserving their antimicrobial activity. These peptides hold promise for both diagnostic and therapeutic applications.

schema-bastien

Publication: É. Pardoux; L. Bastien; R. Mathey; S. Boisset; D. Boturyn; Y. Roupioz, Rapid classification of live bacteria in blood using antimicrobial peptides micro-arrays, Journal of Materials Chemistry B, 2026, DOI: 10.1039/D6TB00941G
PEPTIDES ANTIMICROBIENS ET UTILISATION DE TELS PEPTIDES, Yoann Roupioz ; Didier Boturyn ; Éric Pardoux ; Lucie Bastien ; Sandrine Boisset, France, patent N°: FR2506797. 2025 (Under review)
PEPTIDES ANTIMICROBIENS ET UTILISATION DE TELS PEPTIDES, Yoann Roupioz ; Didier Boturyn ; Éric Pardoux ; Lucie Bastien ; Sandrine Boisset, France, patent N°: FR2506800. 2025 (Under review)
 
Published on  November 17, 2026
Updated on November 17, 2026